Adjuvant Therapy for Women Over Age 65 With Breast Cancer
14
TL;DRAbstract
Women with breast cancer over age 65 whose life expectancy is greater than 5 years, and who are not otherwise too ill, should be given chemotherapy, trastuzumab, and radiotherapy as standard adjuvant treatment. Adjuvant therapy can be reduced or omitted in frail patients. Patients over age 65 should be given the opportunity to enroll in clinical trials.
Chat with Paper
AI Agents for this Paper
Women with breast cancer over age 65 whose life expectancy is greater than 5 years, and who are not otherwise too ill, should be given chemotherapy, trastuzumab, and radiotherapy as standard adjuvant treatment. Adjuvant therapy can be reduced or omitted in frail patients. Patients over age 65 should be given the opportunity to enroll in clinical trials.
Keywords
MedicineBreast cancerRadiation therapyOncologyInternal medicineCancerTrastuzumabAdjuvant therapy
Chat
Click to start Chat